Nizoral (Ketoconazole)

Ketoconazole blocks the fungal enzyme lanosterol 14α‑demethylase, which is essential for producing ergosterol, a key component of fungal cell membranes. Without ergosterol, the membrane becomes defective, leading to increased permeability and fungal cell death. This targeted action reduces the infection while sparing human cells.

The specific amount, frequency, and duration of Nizoral application are determined by the prescribing healthcare professional based on the infection type, severity, and patient factors. Patients should follow the prescriber's instructions and the product labeling for optimal results.

Safety data for topical ketoconazole in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Nizoral.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After verification of trade or institutional credentials, the sales team will provide pricing, availability, shipping details (including any cold‑chain requirements) and assist with import documentation.

Nizoral (ketoconazole) is an azole antifungal, offering broad‑spectrum activity against dermatophytes and yeasts. Compared with allylamine agents such as terbinafine, ketoconazole may have a slightly slower onset but is effective for a wide range of skin infections. Choice of therapy depends on infection type, resistance patterns, patient tolerance and clinician preference.

Nizoral should be stored at room temperature, below 25 °C. Keep the product in its original container, protect it from moisture and direct sunlight, and ensure the cap is tightly closed to maintain stability.

Apply a thin layer of the cream or lotion to the affected skin area once or twice daily, as directed by the prescriber. Gently rub it in until fully absorbed, and wash hands after application. Avoid covering the treated area with occlusive dressings unless instructed.

While uncommon, serious risks include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, or toxic epidermal necrolysis. Patients should seek immediate medical attention if they experience widespread rash, blistering, swelling, or difficulty breathing after using the product.

Individuals with known hypersensitivity to ketoconazole, other azole antifungals, or any component of the formulation should avoid Nizoral. It should also not be used on extensive broken skin, mucous membranes, or in patients where a prescriber determines the risks outweigh the benefits.